Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Stanford University
Filamon LTD
Fondazione del Piemonte per l'Oncologia
Aminex Therapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Psyence Australia Pty Ltd
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
ViroMissile, Inc.
Hummingbird Bioscience
Replimune Inc.
Dana-Farber Cancer Institute
Kaiser Permanente
Mayo Clinic
Washington University School of Medicine
University of Florida
Memorial Sloan Kettering Cancer Center
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
Wake Forest University Health Sciences
Sapience Therapeutics
MacroGenics
Alliance for Clinical Trials in Oncology
Daiichi Sankyo
University of Nebraska
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Second Life Therapeutics
NRG Oncology
Fusion Pharmaceuticals Inc.
University of Southern California
The Netherlands Cancer Institute
OncoNano Medicine, Inc.
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Abramson Cancer Center at Penn Medicine
AstraZeneca
Bayer
Tempus AI
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
Young Adult Survivors United
Virginia Commonwealth University
British Columbia Cancer Agency
Travera Inc
Institut Curie